PuraPharm Corporation Limited (HKG:1498)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
China CCMG	160.77M	172.80M	242.25M	451.05M	350.53M
China CCMG Growth	-6.96%	-28.67%	-46.29%	28.68%	-9.11%
Clinics	56.31M	53.73M	46.11M	50.03M	49.92M
Clinics Growth	4.81%	16.51%	-7.83%	0.21%	-48.22%
Chinese Healthcare Products	85.91M	83.58M	79.28M	79.09M	87.01M
Chinese Healthcare Products Growth	2.78%	5.44%	0.23%	-9.10%	-4.80%
Hong Kong CCMG	212.49M	215.47M	199.41M	170.64M	154.33M
Hong Kong CCMG Growth	-1.38%	8.06%	16.86%	10.57%	-13.05%
Elimination	-156.59M	-156.33M	-208.51M	-136.05M	-83.80M
Plantation	23.21M	37.61M	89.53M	44.83M	43.82M
Plantation Growth	-38.30%	-57.99%	99.72%	2.31%	-59.56%
Total	382.09M	406.86M	448.07M	659.59M	601.82M
Total Growth	-6.09%	-9.20%	-32.07%	9.60%	-13.52%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Hong Kong	305.52M	305.28M	281.53M	242.48M	227.92M
Hong Kong Growth	0.08%	8.44%	16.11%	6.39%	-23.29%
Mainland China	35.32M	62.87M	132.30M	374.09M	323.34M
Mainland China Growth	-43.81%	-52.48%	-64.63%	15.70%	-7.81%
Other Countries/Regions	41.24M	38.71M	34.24M	43.03M	50.55M
Other Countries/Regions Growth	6.54%	13.06%	-20.43%	-14.89%	5.32%
Total	382.09M	406.86M	448.07M	659.59M	601.82M
Total Growth	-6.09%	-9.20%	-32.07%	9.60%	-13.52%

Source: S&P Global Market Intelligence.